Preeclampsia is a disease mainly occurs in pregnant ladies. This disease characterized by high blood pressure and it also damages the other organs of the body. This Preeclampsia disease usually starts after 20-25 weeks of pregnancy in a woman whose blood pressure is in normal stage. Even for simple complications in blood pressure may be a sign of Preeclampsia. Left untreated, preeclampsia can lead to serious — even fatal — complications for both you and your baby. If you have preeclampsia, the only cure is delivery of your baby. If you're diagnosed with preeclampsia too early in your pregnancy to deliver your baby, you and your doctor face a challenging task. Your baby needs more time to mature, but you need to avoid putting yourself or your baby at risk of serious complications.
Sometimes Preeclampsia may develop without any symptoms. High blood pressure may develop slowly, but more commonly it has a sudden onset. Monitoring your blood.
Treatment: The main cure for preeclampsia is only delivery. You're at increased risk of seizures, placental abruption, stroke and possibly severe bleeding until your blood pressure decreases. Of course, if it's too early in your pregnancy, delivery may not be the best thing for your baby. If you're diagnosed with preeclampsia, your doctor will let you know how often you'll need to come in for prenatal visits — likely more frequently than what's typically recommended for pregnancy. You'll also need more-frequent blood tests, ultrasounds and nonstress tests than would be expected in an uncomplicated pregnancy. Possible treatment for preeclampsia may include: Medications to lower blood pressure, Corticosteroids, Anticonvulsant medications
Statistics: In Poland, the analysis on Preeclampsia revealed heightened levels of homocysteine and ADMA in the serum of women with preeclampsia. The frequency of the 1691G>A FV allele in the study group (n = 650) proved to be 1.9%. We identified 626 GG homozygotes, 23 GA heterozygotes, and 1 AA homozygote, conforming to the expected Hardy-Weinberg equilibrium. This gives a summed frequency value for Poland of 2.0% (n = 1588). The average frequency of the 1691G>A FV allele in Central, Eastern and South-Eastern European countries was 3.2 % and varied from 0.6% (Belarus) to 5.1% (Czech Republic).